Keywords: karo, bio, loss, up, costs, swedish, drug

Karo Bio's 2007 loss up 63% on R&D costs

Article | 18 February 2008

Swedish drug discovery company Karo Bio reported an operating loss of 215.8 million Swedish kronor ($33.3 million) for full-year 2007, an increase of 63.5% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Drug Discovery

Merck

Merck KGaA

Wyeth

Go to company listing